Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 6.46 USD 2.22% Market Closed
Market Cap: 832.1m USD
Have any thoughts about
Cytek Biosciences Inc?
Write Note

Wall Street
Price Targets

CTKB Price Targets Summary
Cytek Biosciences Inc

Wall Street analysts forecast CTKB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTKB is 8.52 USD with a low forecast of 7.07 USD and a high forecast of 9.45 USD.

Lowest
Price Target
7.07 USD
9% Upside
Average
Price Target
8.52 USD
32% Upside
Highest
Price Target
9.45 USD
46% Upside

CTKB Last Price Targets
Cytek Biosciences Inc

The latest public price target was made on May 13, 2024 by Dave Westenberg from Piper Sandler , who expects CTKB stock to rise by 32% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Dave Westenberg
Piper Sandler
8.5 USD
Upside 32%
7 months ago
May 13, 2024
Cytek Biosciences Inc (CTKB) PT Lowered to $8.50 at Piper Sandler
StreetInsider
Dave Westenberg
Piper Sandler
Price Target 8.5 USD
Upside/Downside 32%
View Source
Cytek Biosciences Inc Competitors:
Price Targets
301333
R&G PharmaStudies Co Ltd
33% Upside
2268
WuXi XDC Cayman Inc
4% Upside
BANB
Bachem Holding AG
41% Upside
ONT
Oxford Nanopore Technologies PLC
46% Upside
ABCL
Abcellera Biologics Inc
329% Upside
688238
Obio Technology Shanghai Corp Ltd
21% Upside
PPGN
PolyPeptide Group AG
14% Upside
STVN
Stevanato Group SpA
30% Upside

Revenue
Forecast

Revenue Estimate
Cytek Biosciences Inc

For the last 3 years the compound annual growth rate for Cytek Biosciences Inc's revenue is 28%. The projected CAGR for the next 3 years is 10%.

28%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cytek Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Cytek Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CTKB's stock price target?
Price Target
8.52 USD

According to Wall Street analysts, the average 1-year price target for CTKB is 8.52 USD with a low forecast of 7.07 USD and a high forecast of 9.45 USD.

What is Cytek Biosciences Inc's Revenue forecast?
Projected CAGR
10%

For the last 3 years the compound annual growth rate for Cytek Biosciences Inc's revenue is 28%. The projected CAGR for the next 3 years is 10%.

Back to Top